Prospective Study
Copyright ©The Author(s) 2015.
World J Hepatol. Apr 28, 2015; 7(6): 903-909
Published online Apr 28, 2015. doi: 10.4254/wjh.v7.i6.903
Table 2 Clinical and laboratory characteristics at diagnosis
Demographic parameters
Age (yr)34 (16-72)
M/F (n)45/70
Distribution by age, n (%)
< 20 yr8 (9)
20-40 yr63 (72)
> 40 yr29 (34)
Clinical parameters n (%)
Disease onset
Acute8.7 (10)
Chronic63.5 (73)
Subacute27.8 (32)
Ascites62.6 (72)
Hepatomegaly62.6 (72)
Splenomegaly42.6 (49)
Thoraco-abdominal venous collaterals43.5 (50)
Lumber venous collaterals11.3 (13)
Hepatic encephalopathy3.5 (4)
Jaundice40 (46)
Lower limb oedema24.3 (28)
Biological parameters
ALT (ULN)2.5 (1-60)
Bilirubin (mg/dL)20.58 (3-265)
Prothrombin time (%)57 (14-98)
Haemoglobin (g/dL)11.7 (3-17)
RBC (106/mm3)4.5 (1.7-7.9)
WBC (103/mm3)7.7 (1.3-21.5)
Platelet count (/mm3)263212 (29000-695000)
Albumin (g/L)29.4 (16.7-45)
Thrombocytosis n (%)20 (23)
Erythrocytosis n (%)11.3 (13)
Hyperleucocytosis n (%)25.2 (29)
Cholestasis n (%)73.9 (85)
Hyperbilirubinaemia n (%)41.7 (48)
Elevated liver enzymes n (%)49.6 (57)
Liver failure n (%)61.7 (71)
Renal failure n (%)9.5 (11)